SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending due to its active community and ongoing development, including upcoming staking app launch and planned token burns. Community members express excitement about the project's momentum, with some suggesting meetups upon reaching certain market cap milestones. The coin's growing number of watchers and exchange listing contribute to the positive sentiment.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group is trending due to a multi-billion dollar AI infrastructure agreement with Microsoft, sparking excitement and bullish sentiment among investors. The community is actively discussing the potential for significant revenue growth and increased valuation, drawing comparisons to other high-performing AI stocks. This deal validates Nebius as a key player in AI capacity, potentially leading to more partnerships and further expansion.

Eightco Holdings, Inc. is a publicly traded holding company, which operates in the consumer products and e-commerce markets, focusing on developing and deploying innovative technology, and capital solutions to empower small to medium-sized businesses. It operates through the North America and Europe geographical segments. The company was founded in 1966 and is headquartered in Easton, PA.

Eightco Holdings Inc

Eightco Holdings Inc ($OCTO) is trending due to a significant surge, reportedly linked to news of a private placement and strategic investment related to a crypto initiative. The community is actively discussing the stock's massive intraday gains, potential short squeeze dynamics, and comparisons to other high-flying tickers. Some traders express skepticism, pointing to the company's fundamentals and potential dilution, while others remain bullish, anticipating further upside.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community discusses its future growth drivers beyond car sales, particularly its energy business and upcoming 'Las Megas' event showcasing Megapacks. Concerns are also emerging around declining market share and the impact of expiring EV tax credits, sparking debate about Tesla's valuation and long-term prospects. Sentiment is mixed, with bulls citing potential for AI and robotics while bears point to increasing competition and dependence on subsidies.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending amid discussions about its solid-state battery technology and recent demonstrations, including its use in a Ducati motorcycle. Community talking points revolve around the long-term potential, partnership with Volkswagen, and speculation regarding additional OEM partners. Increased short interest is adding to the volatility.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is trending due to its recent verification on Jupiter, a major DEX aggregator within the Solana ecosystem. The community is rallying around this milestone, viewing it as a significant step towards greater trust and visibility. Many are drawing comparisons to early Shiba Inu, highlighting $WAGMI.X's strong community, positive vibes, and potential as a leading culture coin.

Sentage Holdings, Inc. engages in the financial services, which offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China. The company was founded on September 16, 2019 and is headquartered in Shanghai, China.

Sentage Holdings Inc - Ordinary Shares - Class A

Sentage Holdings Inc

SNTG is trending as traders discuss its potential for a significant run, drawing comparisons to recent surges in similar stocks like OCTO. Community members highlight SNTG's low float and potential for a short squeeze, fueling speculative interest. Some traders are also pointing to a potential for increased borrow fees, which could add pressure on shorts.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to anticipation surrounding an upcoming merger vote, with the community buzzing about the potential for a significant short squeeze and comparing it to other high-momentum plays. Bullish sentiment is fueled by the company's move to become a Bitcoin treasury asset manager and potential access to substantial funding, while others are wary of potential dilution post-merger.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI ($SOUN) is trending as investors discuss its potential for a short squeeze and potential major partnership announcements, fueled by recent strong revenue growth and expansion into the healthcare sector. The community highlights the company's unique position in voice AI, particularly its integration with NVIDIA chips, and anticipates further catalysts from the CFO's upcoming conference appearance. Bullish sentiment is strong, with some speculating on significant price appreciation and long-term growth.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries ($FORD) is trending due to a recent $1.65 billion private placement to anchor its Solana treasury strategy, sparking discussions about its potential compared to similar plays like $OCTO. The community is focused on the company's lower float and larger treasury relative to its market cap. Some traders are confusing it with Ford Motor Company ($F), while others anticipate a significant price increase following the news.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates

Ironwood shares jump 9.3% as second-quarter earnings and revenues top estimates. The company maintains its 2025 outlook.

Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates

Ironwood (IRWD) delivered earnings and revenue surprises of +800.00% and +37.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?

Ironwood Pharmaceuticals shares dropped 14.6% on Wednesday after the company reported a steep revenue miss in the first quarter, attributing the shortfall to a timing shift in rebates related to its gastrointestinal drug Linzess.&nbsp;The company maintained its full-year guidance and noted progress on a strategic review and pipeline development.The stock closed at $0.79, down $0.13 on Wednesday, and remained flat in after-hours trading.Ironwood posted Q1 2025 revenue of $41.1 million, down from $74.9 million a year earlier and well below the $56.7 million consensus estimate.&nbsp;GAAP net loss widened to $37.4 million, or $0.23 per share, compared to $0.03 per share in the year-ago quarter. Non-GAAP net loss came in at $0.14 per share.The company attributed the revenue decline to a change in gross-to-net rebate reserve estimates from partner AbbVie, which impacted the phasing of&nbsp;Linzess's U.S. net sales but is not expected to affect full-year results.&nbsp;Collaboration revenue related to Linzess dropped 46% year-over-year to $38.8 million.Ironwood reaffirmed its 2025 U.S. Linzess net sales forecast of $800 million to $850 million and raised its adjusted EBITDA outlook to over $105 million.&nbsp;Prescription demand for Linzess rose 8% year-over-year in Q1, in line with expectations. The company ended the quarter with $108.5 million in cash and cash equivalents, up from $88.6 million at year-end.Management said it will focus on maximizing shareholder value, including through a planned confirmatory Phase 3 trial for apraglutide and an ongoing strategic alternatives review with Goldman Sachs.Analyst sentiment soured as Wells Fargo downgraded the company to 'Equalweight' from 'Overweight,' slashing its price target from $7 to $1, according to Koyfin.Similarly, Jefferies downgraded Ironwood to 'Hold' from 'Buy,' lowering its target from $8 to $0.70, Koyfin data said.&nbsp;On Stocktwits, sentiment was ‘bearish’ amid ‘normal’ message volume.&nbsp;Some users criticized the lack of an earnings call, with one remarking that the company simply dropped the earnings release without discussion — a departure from its decade-long tradition — and instead chose to present at a life sciences conference later in the day.&nbsp;<stembedurl>https://stocktwits.com/TeeMan123/message/613768926</stembedurl><stembedurl>https://stocktwits.com/TeeMan123/message/613804225</stembedurl>Another user noted there was little new information in the earnings release beyond what had already been disclosed on April 25,&nbsp;saying they took advantage of the post-earnings selloff to add shares at a 12% discount.<stembedurl>https://stocktwits.com/Bio_Invest101/message/613802455</stembedurl>Shares of Ironwood have fallen 81.7% so far this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic capsules, 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call

The drugmaker’s first-quarter revenue of $41.1 million came in well below the consensus estimate of $56.7 million, attributed to changes in AbbVie’s gross-to-net rebate reserves. 

Equity

Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its fourth quarter and full year 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday...

Millrose Properties Set to Join S&P SmallCap 600

Millrose Properties Set to Join S&P SmallCap 600 Millrose Properties Set to Join S&P SmallCap 600 PR Newswire NEW YORK, Feb. 5, 2025 NEW YORK, Feb. 5, 2025 /PRNewswire/ -- Millrose Properties Inc...

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, today...

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Jefferies London...

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its third quarter 2024 results and recent business performance. LINZESS continued to deliver robust...

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$0.10	--	--	N/A
Q2 '25	$0.02	$0.14	500.01%	BEAT
Q1 '25	-$0.14	-$0.23	-68.87%	MISSED
Q4 '24	$0.08	$0.02	-76.35%	MISSED
Q3 '24	$0.07	$0.02	-72.22%	MISSED

IRWD
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest IRWD News

IRWD Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A